At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 409 enrolled
Drug / intervention
122-0551 Foam +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)
In Brief
A Phase 3 clinical trial evaluating 122-0551 Foam and Vehicle Foam for Plaque Psoriasis. Completed, enrolled 409 participants across 21 sites.
Detailed Summary
This Phase 3 study (Study 310) has been designed to determine and compare the efficacy and safety of 122-0551 Foam and Vehicle Foam applied twice daily for two weeks in subjects with plaque psoriasis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartJun 2016
Primary CompletionFeb 2017
Study CompletionJun 2017
TodayJul 2026
First PostedApr 19, 2016
Enrollment StartJun 1, 2016
Primary CompletionFeb 27, 2017
Study CompletionJun 16, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.2 years ago
Interventions
122-0551 Foamdrug
Topical Foam containing active drug
Vehicle Foamdrug
Topical Foam containing no active drug